Skip to main content
A Singapore Government Agency Website

HSA Approves "Spikevax" as the New Brand Name for Moderna's COVID-19 Vaccine

The Health Sciences Authority (HSA) has on 14 September 2021 approved the application by Moderna to introduce the brand name “Spikevax” for its COVID-19 vaccine currently authorised under the Pandemic Special Access Route. There are no changes to the vaccine and its quality, safety and efficacy.

HEALTH SCIENCES AUTHORITY
SINGAPORE
14 SEPTEMBER 2021

Download pdf version here 637 KB

Consumer, Healthcare professional, Industry member, Therapeutic Products
Published:

HSA Updates

14 Sep 2021